Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells

Infection and Immunity

Volumn 67, Issue 6, 1999, Pages 3108-3111

  Bermudez, Luiz E ^a   Petrofsky, Mary ^a  

^a Kuzell Institute for Arthritis and Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; FEMALE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0033052476     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.6.3108-3111.1999     Document Type: Article

References (27)

1. Appelberg, R., A. G. Castro, J. Pedrosa, R. A. Silva, I. M. Orme, and P. Minoprio. 1994. Role of gamma Interferon and tumor necrosis factor alpha during T-cell-independent and dependent phases of Mycobacterium avium infection. Infect. Immun. 62:3962-3971.
2. + T-lymphocyte response. Immunology 91:414-420.
3. Bermudez, L. E. 1993. Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma. J. Immunol. 150:1838-1845.
4. Bermudez, L. E., and J. Champsi. 1993. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect. Immun. 61:3093-3096.
5. Bermudez, L. E., P. Kolonoski, and L. S. Young. 1990. Natural killer cell activity and macrophage dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model. J. Leukoc. Biol. 47:135-142.
6. Bermudez, L. E., M. Wu, and L. S. Young. 1995. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium complex. Infect. Immun. 63:4099-4105.
7. Bermudez, L. E., and L. S. Young. 1991. Natural killer cell dependent mycobacteriostatic and mycobactericidal activity in human macrophages. J. Immunol. 146:265-269.
8. Champsi, J., L. S. Young, and L. E. Bermudez. 1995. Production of TNF-α, IL-6 and TGFβ and expression of receptors for TNFα and IL-6 during murine Mycobacterium avium infection. Immunology 84:549-554.
9. Clemens, D. L., and M. A. Horwitz. 1995. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181:257-270.
10. Cooper, A. M., C. D'Souza, A. A. Frank, and I. M. Orme. 1997. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of perform- or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65:1317-1320.
11. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423-432.
12. Doherty, T. M., and A. Sher. 1997. Defects in cell-mediated immunity after chronic, but not innate, resistance of mice to Mycobacterium avium infection. J. Immunol. 158:4822-4831.
13. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013-12017.
14. Hess, J., and S. H. E. Kaufmann. 1997. Salmonella enterica infection. Res. Immunol. 36:581-586.
15. Horsburgh, C. R., Jr. 1991. Mycobacterium avium complex in the acquired immunodeficiency syndrome (AIDS). N. Engl. J. Med. 324:1332-1338.
16. Howard, A. D., O. J. Trans, S. E. Weisbrode, and B. S. Zwilling. 1998. Plenotypic changes in T cell populations during the reactivation of tuberculosis in mice. Clin. Exp. Immunol. 111:309-315.
17. Inderlied, C. B., C. A. Kemper, and L. E. Bermudez. 1993. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:266-310.
18. Laochumroonvapong, P., J. Wang, C. C. Liu, W. Ye, A. L. Moreira, K. B. Elkon, V. H. Freedman, and G. Kaplan. 1997. Perform, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun. 65:127-132.
19. McDonough, K., and Y. Kress. 1995. Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect. Immun. 63:4802-4811.
20. Orme, I. M., S. K. Furney, and A. D. Roberts. 1992. Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retrovirus. Infect. Immun. 60:4747-4753.
21. Roberts, A. D., D. J. Ordway, and I. M. Orme. 1993. Listeria monocytogenes infection in β2 microglobulin-deficient mice. Infect. Immun. 61:1113-1116.
22. Russell, D. G. 1995. Mycobacterium and Leishmania: stowaways in the endosomal network. Trends Cell Biol. 5:125-128.
23. Saunders, B. M., and C. Cheers. 1995. Inflammatory response following intranasal infection of Mycobacterium avium complex: role of T-cell subsets and interferon gamma. Infect. Immun. 63:2282-2287.
24. Saunders, B. M., Y. Zhan, and C. Cheers. 1995. Interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection. Infect. Immun. 63:4011-4015.
25. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddix, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, and D. G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263:678-681.
26. + T cells requires the production of gamma interferon. Infect. Immun. 66:830-834.
27. + T cells and natural killer cells. Proc. Natl. Acad. Sci. USA 95:12492-12497.